Could your own immune cells fight ALS? early trial begins
Disease control
Recruiting now
This early-stage trial is testing whether a special type of immune cell, called regulatory T cells (Tregs), is safe for people with ALS. The cells are taken from each patient's own blood, multiplied in a lab, and then injected into the spinal fluid. The study will enroll 12 adult…
Phase: PHASE1 • Sponsor: Novabio Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC